You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

 

Online download statistics by month:

Online download statistics by month: January 2022 to September 2025

AbstractFullPdf
Jan 2022498531232
Feb 2022270287115
Mar 2022206216100
Apr 202216116645
May 202216918184
Jun 202213914660
Jul 202213413955
Aug 202215916554
Sep 202213513869
Oct 202214915970
Nov 202210510644
Dec 202211611754
Jan 2023808133
Feb 202310410439
Mar 2023788170
Apr 2023525335
May 2023525239
Jun 2023575930
Jul 2023818257
Aug 2023616337
Sep 2023495026
Oct 2023596060
Nov 2023575837
Dec 2023434424
Jan 2024434324
Feb 2024494927
Mar 2024646480
Apr 2024727237
May 2024687130
Jun 2024586035
Jul 2024727540
Aug 2024597927
Sep 2024454523
Oct 2024757596
Nov 2024495035
Dec 2024112115142
Jan 202512412591
Feb 202524924936
Mar 2025808265
Apr 2025888853
May 2025485134
Jun 2025454531
Jul 2025110
Sep 2025110
Total441645782375